Azienda Ospedaliero Universitaria Ospedali Riuniti

Torrette 60020

0 studies enrolling now · 1 studies all time

What they study most

Squamous Cell Carcinoma of the Anal Canal

Studies at this site

• Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2). — Completed